Evaluating vaccines to prevent HIV using nonhuman primates
Official title: Simian Vaccine Evaluation Unit: Core Activities - Administrative and Technical Support
Funded at University of Louisiana at Lafayette · NIH-11060167 · Data updated 2026-11-12
This study is testing new AIDS vaccines in monkeys to see how well they can prevent HIV, helping researchers learn more about how to make these vaccines better for people in the future.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Louisiana at Lafayette NIH-funded |
| Lab location | 1 site (Lafayette, United States) |
| Project start | April 1, 2020 |
| Project end | March 31, 2027 |
| Funding year | 2024 |
| Award (this year) | $296,844 |
| NIH project number | 75N93020D00008-P00004-759302000001-1 |
| Project ID | NIH-11060167 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for benefiting from this research include individuals at high risk for HIV infection who may eventually receive effective vaccines developed through these studies.
✕Less likely to help
Patients who are already living with HIV or those who do not have access to vaccination programs may not benefit directly from this research.
What this research studies
This research focuses on the evaluation of candidate AIDS vaccines using nonhuman primates (NHPs) to better understand their effectiveness in preventing HIV. The Simian Vaccine Evaluation Units (SVEUs) provide essential resources for conducting preclinical studies, allowing researchers to assess immune responses and vaccine efficacy. By utilizing NHP models, the research aims to identify correlates of reduced risk of virus acquisition and enhance the immunogenicity of clinical vaccines. This program supports all stages of AIDS vaccine research, from initial evaluations to clinical testing.
Why it matters
Potential benefit: If successful, this research could lead to the development of effective vaccines that prevent HIV infection, significantly improving public health outcomes.
How similar studies have gone: Previous research using nonhuman primate models has shown promise in evaluating HIV vaccines, indicating that this approach has potential for success.
Where this research is happening
-
University of Louisiana at Lafayette
Lafayette, United States Active
Researchers
- Principal investigator: Villinger, Francois — University of Louisiana at Lafayette
- Study coordinator: Villinger, Francois
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.